The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Propionate Ameliorates Dextran Sodium Sulfate-Induced Colitis by Improving Intestinal Barrier Function and Reducing Inflammation and Oxidative Stress
Open accessAbstract
Propionate is a short chain fatty acid that is abundant as butyrate in the gut and blood. However, propionate has not been studied as extensively as butyrate in the treatment of colitis. The present study was to investigate the effects of sodium propionate on intestinal barrier function, inflammation and oxidative stress in dextran sulfate sodium (DSS)-induced colitis mice. Animals in DSS group received drinking water from 1 to 6 days and DSS [3% (w/v) dissolved in double distilled water] instead of drinking water from 7 to 14 days. Animals in DSS+propionate (DSS+Prop) group were given 1% sodium propionate for 14 consecutive days and supplemented with 3% DSS solution on day 7-14. Intestinal barrier function, proinflammatory factors, oxidative stress, and signal transducer and activator of transcription 3 (STAT3) signaling pathway in the colon were determined. It was found that sodium propionate ameliorated body weight loss, colon-length shortening and colonic damage in colitis mice. Sodium propionate significantly inhibited the increase of FITC-dextran in serum and the decrease of zonula occludens-1 (ZO-1), occludin, and E-cadherin expression in the colonic tissue. It also inhibited the expression of interleukin (IL)-1β, IL-6, and tumor necrosis factor-α (TNF-α) mRNA and phosphorylation of STAT3 in colitis mice markedly, reduced the myeloperoxidase (MPO) level, and increased the superoxide dismutase and catalase level in colon and serum compared with DSS group. Sodium propionate inhibited macrophages with CD68 marker infiltration into the colonic mucosa of colitis mice. These results suggest that oral administration of sodium propionate could ameliorate DSS-induced colitis mainly by improving intestinal barrier function and reducing inflammation and oxidative stress via the STAT3 signaling pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Review article: the role of butyrate on colonic function
HAMER, H. M., JONKERS, D., VENEMA, K., VANHOUTVIN, S., TROOST, F. J., & BRUMMER, R. ‐. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03562.x · Cited by 2,721
Chemically induced mouse models of intestinal inflammation
Wirtz, S., Neufert, C., Weigmann, B., & Neurath, M. F. (2007) · Nature Protocols · doi:10.1038/nprot.2007.41 · Cited by 1,567
Tedelind, S., Westberg, F., Kjerrulf, M., & Vidal, A. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i20.2826 · Cited by 853
Intestinal Permeability Regulation by Tight Junction: Implication on Inflammatory Bowel Diseases
Lee, S. H. (2015) · Intestinal Research · doi:10.5217/ir.2015.13.1.11 · Cited by 807
Vinolo, M. A. R., Rodrigues, H. G., Hatanaka, E., Sato, F. T., Sampaio, S. C., & Curi, R. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.07.009 · Cited by 708
Peng, L., He, Z., Chen, W., Holzman, I. R., & Lin, J. (2007) · Pediatric Research · doi:10.1203/01.pdr.0000250014.92242.f3 · Cited by 518
Inflammatory Bowel Disease: Genetics, Epigenetics, and Pathogenesis
Loddo, I., & Romano, C. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00551 · Cited by 449
Butyrate and other short-chain fatty acids as modulators of immunity: What relevance for health?
Meijer, K., de Vos, P., & Priebe, M. G. (2010) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32833eebe5 · Cited by 443
Intestinal Inflammation and Mucosal Barrier Function
Sánchez de Medina, F., Romero-Calvo, I., Mascaraque, C., & Martínez-Augustin, O. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000204 · Cited by 434
Butyrate modulates oxidative stress in the colonic mucosa of healthy humans
Hamer, H. M., Jonkers, D. M. A. E., Bast, A., Vanhoutvin, S. A. L. W., Fischer, M. A. J. G., Kodde, A., Troost, F. J., Venema, K., & Brummer, R.-J. M. (2009) · Clinical Nutrition · doi:10.1016/j.clnu.2008.11.002 · Cited by 400
Piechota-Polanczyk, A., & Fichna, J. (2014) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-014-0985-1 · Cited by 390
Suzuki, T., Yoshida, S., & Hara, H. (2008) · British Journal of Nutrition · doi:10.1017/s0007114508888733 · Cited by 355
Short chain fatty acids and colonic health
Hijová, E., & Chmelařová, A. (2007) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/bf03656953 · Cited by 295
Ciobica, A., Balmus, I., Trifan, A., & Stanciu, C. (2016) · Saudi Journal of Gastroenterology · doi:10.4103/1319-3767.173753 · Cited by 292
Oxidative stress in ulcerative colitis-associated carcinogenesis
Roessner, A., Kuester, D., Malfertheiner, P., & Schneider-Stock, R. (2008) · Pathology - Research and Practice · doi:10.1016/j.prp.2008.04.011 · Cited by 271
The Pharmacology and Function of Receptors for Short-Chain Fatty Acids
Bolognini, D., Tobin, A. B., Milligan, G., & Hodge, D. (2016) · Molecular Pharmacology · doi:10.1124/mol.115.102301 · Cited by 267
Elhaseen E., E., Ad A., M., Jan, D., Harm-Jan, P., & Daisy M., J. (2013) · The Journal of Nutrition · doi:10.3945/jn.113.179549 · Cited by 238
Hamer, H. M., Jonkers, D. M. A. E., Vanhoutvin, S. A. L. W., Troost, F. J., Rijkers, G., de Bruïne, A., Bast, A., Venema, K., & Brummer, R.-J. M. (2010) · Clinical Nutrition · doi:10.1016/j.clnu.2010.04.002 · Cited by 193
Effect of short-chain fatty acids on paracellular permeability in Caco-2 intestinal epithelium model
Mariadason, J. M., Barkla, D. H., & Gibson, P. R. (1997) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1997.272.4.g705 · Cited by 182
Clausen, M. R., Bonnén, H., & Mortensen, P. B. (1991) · Gut · doi:10.1136/gut.32.8.923 · Cited by 135
Short-Chain Fatty Acid in the Human Colon
D’Argenio, G., & Mazzacca, G. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-1-4757-3230-6_13 · Cited by 106
Impact of environmental and dietary factors on the course of inflammatory bowel disease
Cabré, E. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i29.3814 · Cited by 103
STAT3-Activating Cytokines: A Therapeutic Opportunity for Inflammatory Bowel Disease?
Nguyen, P. M., Putoczki, T. L., & Ernst, M. (2015) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2014.0225 · Cited by 100
Moussaoui, N., Braniste, V., Ait-Belgnaoui, A., Gabanou, M., Sekkal, S., Olier, M., Théodorou, V., Martin, P. G. P., & Houdeau, É. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088382 · Cited by 88
Modulation of distal colonic epithelial barrier function by dietary fibre in normal rats
Mariadason, J. M., Catto‐Smith, A. G., & Gibson, P. R. (1999) · Gut · doi:10.1136/gut.44.3.394 · Cited by 85
Butyrate protects Caco-2 cells from Campylobacter jejuni invasion and translocation
Deun, K. V., Pasmans, F., Immerseel, F. V., Ducatelle, R., & Haesebrouck, F. (2008) · British Journal Of Nutrition · doi:10.1017/s0007114508921693 · Cited by 78
Bacterial fermentation of complex carbohydrate in the human colon
Hill, M. J. (1995) · European Journal of Cancer Prevention · doi:10.1097/00008469-199510000-00004 · Cited by 76
Caprioli, F., Bosè, F., Rossi, R. L., Petti, L., Viganò, C., Ciafardini, C., Raeli, L., Basilisco, G., Ferrero, S., Pagani, M., et al. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e318280292b · Cited by 72
Wang, H.-G., Shi, P., Zuo, L., Dong, J., Zhao, J., Liu, Q., & Zhu, W. (2016) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjw065 · Cited by 72
Increasing the Permeability of the Blood–brain Barrier in Three Different Models in vivo
Liu, W., Wang, Z., Wang, Y., Tong, L., Li, Y., Wei, X., Luan, P., & Li, L. (2015) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12405 · Cited by 64
Self-citationStat3: Friend or Foe in Colitis and Colitis-associated Cancer?
Han, J., & Theiss, A. L. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000180 · Cited by 52
Metabolic regulation of intestinal epithelial barrier during inflammation
Colgan, S. P., Curtis, V. F., Lanis, J. M., & Glover, L. E. (2014) · Tissue Barriers · doi:10.4161/21688362.2014.970936 · Cited by 51
The Future of IBD Therapy: Where Are We and Where Should We Go Next?
Mao, R., & Hu, P. (2016) · Digestive Diseases · doi:10.1159/000443135 · Cited by 47
Quetglas, E. G., Mujagic, Z., Wigge, S., Keszthelyi, D., Wachten, S., Masclee, A., & Reinisch, W. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i44.12519 · Cited by 28
Huang, N., & Wu, G. D. (1997) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-5967-2_16 · Cited by 11
Inflammatory Bowel Disease Genetics
Cotterill, L. (2011) · Research Explorer (The University of Manchester) · Cited by 11
Zhang, L., Li, Z., Yu, Y., Wang, Z.-B., Wei, X., Su, D., & Li, L. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.1398 · Cited by 10
Self-citation
Cited by
Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286
Human gut microbiota/microbiome in health and diseases: a review
Gomaa, E. Z. (2020) · Antonie van Leeuwenhoek · doi:10.1007/s10482-020-01474-7 · Cited by 1,294
van de Wouw, M., Boehme, M., Lyte, J. M., Wiley, N., Strain, C., O'Sullivan, O., Clarke, G., Stanton, C., Dinan, T. G., & Cryan, J. F. (2018) · The Journal of Physiology · doi:10.1113/jp276431 · Cited by 789
Role of gut microbiota-generated short-chain fatty acids in metabolic and cardiovascular health
Chambers, E. S., Preston, T., Frost, G., & Morrison, D. J. (2018) · Current Nutrition Reports · doi:10.1007/s13668-018-0248-8 · Cited by 691
Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer
Fong, W., Li, Q., & Yu, J. (2020) · Oncogene · doi:10.1038/s41388-020-1341-1 · Cited by 613
Metadata
- Authors
- Tong, L.-C., Wang, Y., Wang, Z.-B., Liu, W.-Y., Sun, S., Li, L., Su, D.-F., & Zhang, L.-C.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2016-08-15
- Volume
- 7
- Pages
- 253-253
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W2513148641
- Cited by
- 331
- References
- 37
- FWCI
- 11.74
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.